We are a professional consulting company specialized in supporting the pharmaceutical, medical device, cosmetic and chemical industry in their efforts to develop effective and safe products by providing preclinical / toxicological and clinical expert services of highest quality.
Gained by the Leadership Team, ACA-pharma concept GmbH is based upon wide experience within the pharmaceutical and consulting industries as well as academia.
In close collaboration with highly experienced partners, ACA-pharma concept GmbH can accompany your projects from the first step through to its successful completion. As required, we establish bespoke teams with the optimal composition and subject matter expertise to fully achieve client objectives. This guarantees flexibility, accuracy, consistency and high quality, and also allows to adapt easily to your special requests.
Supporting pharmaceutical and biotech companies, in particular start-ups in developing effective and safe human and veterinary medicinal products by providing preclinical and clinical expert services of highest quality is a core competence of ACA-pharma concept GmbH.
ACA-pharma concept GmbH is specialized in the development and CE-marking of medical devices for the European market, comprising in particular those medical devices incorporating an ancillary drug substance and in vitro diagnostics. Our services may largely vary, they may be limited to strategic support or borderline assessments but in close collaboration with our partners they can also comprise entire project management.
ACA-pharma concept GmbH provides an overall solution for complying with REACH (Registration, Evaluation and Authorisation of Chemicals) regulation requirements according to EC1907/2006.
ACA-pharma concept GmbH is specialized in the development of animal dietary supplements for pets, also those including botanicals.
ACA offers the regulatory and scientific expertise necessary to provide reliable advice and support for launching a cosmetic product that complies with current EU regulations.